GREAT NECK, N.Y., May 20, 2019 /PRNewswire/ -- Spatz Medical today announced the FDA trial results of its innovative adjustable gastric balloon. The results demonstrate that the Spatz3 balloon is ...

FORT LAUDERDALE, Fla., Oct. 25, 2021 /PRNewswire-PRWeb/ -- Spatz FGIA, Inc., an international pioneer in gastrointestinal weight loss solutions, today announced that the U.S. Food and Drug ...

The Spatz3 Adjustable Gastric Balloon, renowned as the first and only adjustable gastric balloon, has earned widespread acclaim for its outstanding weight loss results and an impressive 84% success ...

GREAT NECK, New York, Jan. 13, 2014 /PRNewswire/ -- Spatz FGIA, Inc., makers of the Spatz Adjustable Intragastric Balloon, announces encouraging results of a recent study on weight loss maintenance.

Spatz3 is the fifth balloon to receive FDA approval and its pivotal FDA clinical trial results demonstrated a 15% decrease in weight and an 84% success rate. The Spatz adjustability function has ...

For the past 30 years, gastric balloons have helped hundreds of thousands of people lose weight with a 15-minute non-surgical out-patient procedure. "The idea for developing an adjustable balloon was ...